Company: OPGN
Filing Date: 2025-10-31
Form Type: 10-Q
Source: 0001829126-25-008771
Chunk: 58

Company: OPGEN INC
Filing Date: 2025-10-31
Form: 10-Q
Item: Part I, Item 8
Chunk 58
---
 and six months ended June 30, 2025 and 2024 as follows:

    Schedule of earnings per share, basic and diluted

    Basic

    Diluted

    Three months ended 
June 30,  
    Three months ended 
June 30, 

    2025  
    2024  
    2025  
    2024 
  
    Net income (loss)
     
    $
    3,509,992

    $
    (1,576,349
    )
     
    $
    3,509,992

    $
    (1,576,349
    )
  
    Net income allocated to preferred stock

    (21,166
    )

    -

    (20,967
    )

    -

    Net income (loss) available to common stockholders
     
    $
    3,488,826

    $
    (1,576,349
    )
     
    $
    3,489,025

    $
    (1,576,349
    )

    Basic weighted average shares outstanding

    10,071,286

    1,340,285

    10,071,286

    1,340,285

    Dilutive effect of stock purchase warrants

    55,424

    -

    Dilutive effect of restricted stock units

    40,857

    -

    Dilutive weighted average shares outstanding

    10,167,567

    1,340,285

    Earnings (loss) per share
     
    $
    0.35

    $
    (1.18
    )
     
    $
    0.34

    $
    (1.18
    )

    Basic  
    Diluted 

    Six months ended 
June 30,  
    Six months ended
 June 30, 

    2025  
    2024  
    2025  
    2024 
  
    Net income (loss) 
    $3,101,859  
    $(1,288,382) 
    $3,101,859  
    $(1,288,382)
  
    Net income allocated to preferred stock 
     (18,705) 
     -  
     - 
     - 
  
    Net income (loss) available to common stockholders